-
Subject Areas on Research
-
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.
-
A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting.
-
A pressing situation.
-
A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.
-
Abdominal migraine: prophylactic treatment and follow-up.
-
Acute histologic effects of extraesophageal reflux on vocal fold healing.
-
Advances in the nontransplant medical and surgical management of intestinal failure.
-
Adverse drug events in high risk older outpatients.
-
Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
-
Alvimopan Provides Additional Improvement in Outcomes and Cost Savings in Enhanced Recovery Colorectal Surgery.
-
As Infliximab Use for Ulcerative Colitis Has Increased, so Has the Rate of Surgical Resection.
-
Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice.
-
Celecoxib (celebrex) increases canine lower esophageal sphincter pressure.
-
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
-
Covert hepatic encephalopathy: not as minimal as you might think.
-
Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig.
-
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
-
Emerging treatments for ulcerative colitis: a systematic review.
-
Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study.
-
Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients.
-
Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
-
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.
-
Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition.
-
Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
-
Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.
-
Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.
-
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
-
Infliximab maintenance therapy for fistulizing Crohn's disease.
-
Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography.
-
Medication prescribing practices for older prisoners in the Texas prison system.
-
Menetrier's disease treated with octreotide long-acting release.
-
Metoclopramide Reduces Fluoroscopy and Procedure Time during Gastrojejunostomy Tube Placement: A Placebo-Controlled Trial.
-
Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea.
-
Osteoporosis piece of multi-morbidity puzzle in geriatric care.
-
Promotility agents for the treatment of ileus in adult surgical patients: A practice management guideline from the Eastern Association for the Surgery of Trauma.
-
Quantifying women's stated benefit-risk trade-off preferences for IBS treatment outcomes.
-
Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
-
Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
-
The Impact of Alvimopan on Return of Bowel Function After Major Spine Surgery - A Prospective, Randomized, Double-Blind Study.
-
The Impact of Risk Factors of Chronic Pancreatitis on Secretin Pancreatic Function Testing: Results of a 20-Year Study.
-
The role of GIP in α-cells and glucagon secretion.
-
Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
-
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome.